Druck Icon

Eckert & Ziegler: Increase of Result before Tax

Berlin, 12.08.2003. Eckert & Ziegler AG (ISIN DE 0005659700), a specialist in medical and industrial isotope applications, was able to increase its result before tax to 224 TEUR in the first half year of 2003 (2002: -597 TEUR) despite the weak dollar. Total turnover dropped to approximately 13 million EUR (nominally, off by almost 20%; adjusted to account for dollar fluctuations in the market, however, the drop was really about 10%). Cash and marketable securities in contrast increased significantly from 5.5 Mio. EUR to 8.1 Mio EUR, despite a reduction of debt and expenses for a share buy back program.

"The revenue decline is mainly attributable to the sale of a business segment and the expected drop in the sales of cardiology products", explained CEO Dr. Andreas Eckert. "In the other areas we saw stable or increasing turnover. We expect this trend to continue, the more since we recently had a number of successful product introductions in the oncology and the nuclear imaging segment."

The Board of Directors